Cargando…

Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis

BACKGROUND: Diabetes cognitive impairment (DCI) is a common diabetic central nervous system disorder that severely affects the quality of life of patients. Qishiwei Zhenzhu Pills (Ranasampel) is a valuable Tibetan medicine formula with the ability to improve cerebral blood vessels, protect nerves an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zhiyi, Zong, Yonghua, Zhang, Chengfei, Han, Zekun, Wu, Lili, Qin, Lingling, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814129/
https://www.ncbi.nlm.nih.gov/pubmed/36620773
http://dx.doi.org/10.3389/fnagi.2022.1033128
_version_ 1784864067886776320
author Yan, Zhiyi
Zong, Yonghua
Zhang, Chengfei
Han, Zekun
Wu, Lili
Qin, Lingling
Liu, Tonghua
author_facet Yan, Zhiyi
Zong, Yonghua
Zhang, Chengfei
Han, Zekun
Wu, Lili
Qin, Lingling
Liu, Tonghua
author_sort Yan, Zhiyi
collection PubMed
description BACKGROUND: Diabetes cognitive impairment (DCI) is a common diabetic central nervous system disorder that severely affects the quality of life of patients. Qishiwei Zhenzhu Pills (Ranasampel) is a valuable Tibetan medicine formula with the ability to improve cerebral blood vessels, protect nerves and improve learning and memory, which has also been widely verified in clinical and basic research. Currently, the prevention and treatment of DCI are still in the exploratory research stage, and the use of Ranasampel will provide new ideas and insights for its treatment. OBJECTIVE: This study is to explore the absorbed components in serum derived from Ranasampel using serum pharmacochemistry, then identify the potential mechanism of Ranasampel for the treatment of DCI through bioinformatics and microarray data validation. METHODS: The UPLC-Q-Exactive MS/MS-based serum pharmacochemistry method was conducted to identify the main active components in serum containing Ranasampel. Then, these components were used to predict the possible biological targets of Ranasampel and explore the potential targets in treating DCI by overlapping with differentially expressed genes (DEGs) screened from Gene Expression Omnibus datasets. Afterward, the protein–protein interaction network, enrichment analyses, hub gene identification, and co-expression analysis were used to study the potential mechanism of Ranasampel. Particularly, the hub genes and co-expression transcription factors were further validated using hippocampal expression profiles of db/db mice treated with Ranasampel, while the Morris water-maze test and H&E staining were used to assess the spatial learning and memory behaviors and histopathological changes. RESULTS: Totally, 40 compounds derived from Ranasampel had been identified by serum sample analysis, and 477 genes related to these identified compounds in Ranasampel, 110 overlapping genes were collected by the intersection of Ranasampel target genes and DEGs. Further comprehensive analysis and verification emphasized that the mechanism of Ranasampel treatment of DCI may be related to the improvement of learning and memory function as well as insulin resistance, hyperglycemia-induced neuronal damage, and neuroinflammation. CONCLUSION: This study provided useful strategies to explore the potential material basis for compound prescriptions such as Ranasampel. These hub genes and common pathways also provided new ideas for further study of therapeutic targets of DCI and the pharmacological mechanism of Ranasampel.
format Online
Article
Text
id pubmed-9814129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98141292023-01-06 Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis Yan, Zhiyi Zong, Yonghua Zhang, Chengfei Han, Zekun Wu, Lili Qin, Lingling Liu, Tonghua Front Aging Neurosci Aging Neuroscience BACKGROUND: Diabetes cognitive impairment (DCI) is a common diabetic central nervous system disorder that severely affects the quality of life of patients. Qishiwei Zhenzhu Pills (Ranasampel) is a valuable Tibetan medicine formula with the ability to improve cerebral blood vessels, protect nerves and improve learning and memory, which has also been widely verified in clinical and basic research. Currently, the prevention and treatment of DCI are still in the exploratory research stage, and the use of Ranasampel will provide new ideas and insights for its treatment. OBJECTIVE: This study is to explore the absorbed components in serum derived from Ranasampel using serum pharmacochemistry, then identify the potential mechanism of Ranasampel for the treatment of DCI through bioinformatics and microarray data validation. METHODS: The UPLC-Q-Exactive MS/MS-based serum pharmacochemistry method was conducted to identify the main active components in serum containing Ranasampel. Then, these components were used to predict the possible biological targets of Ranasampel and explore the potential targets in treating DCI by overlapping with differentially expressed genes (DEGs) screened from Gene Expression Omnibus datasets. Afterward, the protein–protein interaction network, enrichment analyses, hub gene identification, and co-expression analysis were used to study the potential mechanism of Ranasampel. Particularly, the hub genes and co-expression transcription factors were further validated using hippocampal expression profiles of db/db mice treated with Ranasampel, while the Morris water-maze test and H&E staining were used to assess the spatial learning and memory behaviors and histopathological changes. RESULTS: Totally, 40 compounds derived from Ranasampel had been identified by serum sample analysis, and 477 genes related to these identified compounds in Ranasampel, 110 overlapping genes were collected by the intersection of Ranasampel target genes and DEGs. Further comprehensive analysis and verification emphasized that the mechanism of Ranasampel treatment of DCI may be related to the improvement of learning and memory function as well as insulin resistance, hyperglycemia-induced neuronal damage, and neuroinflammation. CONCLUSION: This study provided useful strategies to explore the potential material basis for compound prescriptions such as Ranasampel. These hub genes and common pathways also provided new ideas for further study of therapeutic targets of DCI and the pharmacological mechanism of Ranasampel. Frontiers Media S.A. 2022-12-22 /pmc/articles/PMC9814129/ /pubmed/36620773 http://dx.doi.org/10.3389/fnagi.2022.1033128 Text en Copyright © 2022 Yan, Zong, Zhang, Han, Wu, Qin and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Yan, Zhiyi
Zong, Yonghua
Zhang, Chengfei
Han, Zekun
Wu, Lili
Qin, Lingling
Liu, Tonghua
Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title_full Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title_fullStr Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title_full_unstemmed Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title_short Exploring the role of Tibetan medicinal formula Qishiwei Zhenzhu Pills (Ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
title_sort exploring the role of tibetan medicinal formula qishiwei zhenzhu pills (ranasampel) against diabetes mellitus-linked cognitive impairment of db/db mice through serum pharmacochemistry and microarray data analysis
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814129/
https://www.ncbi.nlm.nih.gov/pubmed/36620773
http://dx.doi.org/10.3389/fnagi.2022.1033128
work_keys_str_mv AT yanzhiyi exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT zongyonghua exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT zhangchengfei exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT hanzekun exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT wulili exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT qinlingling exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis
AT liutonghua exploringtheroleoftibetanmedicinalformulaqishiweizhenzhupillsranasampelagainstdiabetesmellituslinkedcognitiveimpairmentofdbdbmicethroughserumpharmacochemistryandmicroarraydataanalysis